«A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease». One Health & Risk Management , bd. 4, nr. 4, september 2023, s. 19-26, https://doi.org/10.38045/ohrm.2023.4.02.